Company / Working Capital
Wave Life Sciences Ltd. Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$519.7M
FY2025
5-year range
$27.0M / $519.7M
FY2021-FY2025
Trend
+148.2%
vs FY2024
Sector context
#86 of 213
Health Care
What the data says
At $520M, Wave Life Sciences Ltd.'s working capital ranks #86 of 213 in the Health Care sector. Working Capital has increased for 3 consecutive years, from $27M in FY2022 to $520M in FY2025.
Based on SEC 10-K filings.
$520M in FY2025 with a 5-year CAGR of +36.7%.
Improved from $49M to $520M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +168.0%
- 5-Year CAGR
- +36.7%
- 10-Year CAGR
- -
Sector benchmark
#86 of 213 in Health CareTop 40% of 213This company $519.7M Sector average $934.6M
▼
-44.4% below sector average
Key checks
Key Insights
- Wave Life Sciences Ltd.'s working capital has grown for 3 consecutive years.
- 5-year CAGR of +36.7%, indicating consistent growth.
- In FY2025, working capital increased 148.2% year-over-year.
- Ranks #86 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $519.7M | +148.2% |
| FY2024 | $209.4M | +328.0% |
| FY2023 | $48.9M | +81.1% |
| FY2022 | $27.0M | -72.5% |
| FY2021 | $98.4M | -9.8% |
| FY2020 | $109.0M | +61.9% |
| FY2019 | $67.3M | -6.8% |
| FY2018 | $72.2M | -45.4% |
| FY2017 | $132.3M | -5.4% |
| FY2016 | $139.8M | -11.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026